Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Ehninger

Showing results (231-240 of 403) with videos related to

Pageof 41
Sort By:
Haematologica|September 7, 2012
Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trialKatja Sockel, Martin Bornhaeuser, Eva Mischak-Weissinger, et al.
Biochimica Et Biophysica Acta|October 19, 2013
MiR-134-mediated β1 integrin expression and function in mesenchymal stem cellsDavid M Poitz, Friedrich Stölzel, Laleh Arabanian, et al.
Haematologica|May 13, 2008
Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemiaDorle Messerer, Jutta Engel, Joerg Hasford, et al.
Blood Cells, Molecules & Diseases|May 4, 2002
Determination of alpha-1 acid glycoprotein in patients with Ph+ chronic myeloid leukemia during the first 13 weeks of therapy with STI571Philipp le Coutre, Karl-Anton Kreuzer, Il-Kang Na, et al.
Proteomes|February 15, 2018
Pilot Study on Mass Spectrometry-Based Analysis of the Proteome of CD34⁺CD123⁺ Progenitor Cells for the Identification of Potential Targets for Immunotherapy in Acute Myeloid LeukemiaJohannes R Schmidt, Elke Rücker-Braun, Katharina Heidrich, et al.
Plos One|April 5, 2014
A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cellsMarc Cartellieri, Stefanie Koristka, Claudia Arndt, et al.
Journal of Hematology & Oncology|November 9, 2016
Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning: a report on behalf of the acute leukemia working party of European group for blood and marrow transplantationAvichai Shimoni, Myriam Labopin, Bipin Savani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2012
MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantationMartin Wermke, Anne Schmidt, Jan Moritz Middeke, et al.
Leukemia & Lymphoma|May 17, 2017
Impact of pharmacokinetics on the toxicity and efficacy of clofarabine in patients with relapsed or refractory acute myeloid leukemiaBozena Büttner, Holger Knoth, Michael Kramer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemiaTilmann Bochtler, Friedrich Stölzel, Christoph E Heilig, et al.
Pageof 41

Showing results (231-240 of 403) with videos related to

Sort By:
Pageof 41
Haematologica|September 7, 2012
Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trialKatja Sockel, Martin Bornhaeuser, Eva Mischak-Weissinger, et al.
Biochimica Et Biophysica Acta|October 19, 2013
MiR-134-mediated β1 integrin expression and function in mesenchymal stem cellsDavid M Poitz, Friedrich Stölzel, Laleh Arabanian, et al.
Haematologica|May 13, 2008
Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemiaDorle Messerer, Jutta Engel, Joerg Hasford, et al.
Blood Cells, Molecules & Diseases|May 4, 2002
Determination of alpha-1 acid glycoprotein in patients with Ph+ chronic myeloid leukemia during the first 13 weeks of therapy with STI571Philipp le Coutre, Karl-Anton Kreuzer, Il-Kang Na, et al.
Proteomes|February 15, 2018
Pilot Study on Mass Spectrometry-Based Analysis of the Proteome of CD34⁺CD123⁺ Progenitor Cells for the Identification of Potential Targets for Immunotherapy in Acute Myeloid LeukemiaJohannes R Schmidt, Elke Rücker-Braun, Katharina Heidrich, et al.
Plos One|April 5, 2014
A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cellsMarc Cartellieri, Stefanie Koristka, Claudia Arndt, et al.
Journal of Hematology & Oncology|November 9, 2016
Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning: a report on behalf of the acute leukemia working party of European group for blood and marrow transplantationAvichai Shimoni, Myriam Labopin, Bipin Savani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2012
MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantationMartin Wermke, Anne Schmidt, Jan Moritz Middeke, et al.
Leukemia & Lymphoma|May 17, 2017
Impact of pharmacokinetics on the toxicity and efficacy of clofarabine in patients with relapsed or refractory acute myeloid leukemiaBozena Büttner, Holger Knoth, Michael Kramer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemiaTilmann Bochtler, Friedrich Stölzel, Christoph E Heilig, et al.
Pageof 41